STERIS plc
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2022 | 2023 | 2024 | 2025 | 2026 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 4.22B | 4.54B | 5.14B | 5.46B | 5.94B | 8.7% | |
| Cost of Revenue | (2.34B) | (2.56B) | (2.92B) | (3.06B) | (3.31B) | 8.3% | |
Gross Profit | 1.88B | 1.98B | 2.22B | 2.40B | 2.63B | 9.3% | |
| Operating Expenses | |||||||
| Research & Development | (86.66M) | (98.48M) | (103.68M) | (107.65M) | (112.90M) | 4.9% | |
| Selling, General & Administrative | (1.32B) | (1.09B) | (1.25B) | (1.33B) | (1.41B) | 5.5% | |
| Depreciation & Amortization | (553.10M) | (422.53M) | (565.24M) | (476.21M) | (486.50M) | 2.2% | |
Operating Income (EBIT) | 477.81M | 791.10M | 836.12M | 866.64M | 1.10B | 27.1% | |
| Non-Operating Items | |||||||
| Interest Income | 6.28M | — | 11.04M | 8.40M | 9.80M | 16.6% | |
| Interest Expense | (89.49M) | (110.83M) | (144.35M) | (86.26M) | (60.70M) | -29.6% | |
| Other Income/Expenses (Net) | -111.01M | -110.83M | -133.31M | -70.43M | -54.50M | -22.6% | |
Income Before Tax | 366.80M | 680.27M | 702.81M | 796.21M | 1.05B | 31.5% | |
| Income Tax Expense | (82.34M) | (124.07M) | (149.53M) | (184.65M) | (262.20M) | 42.0% | |
Net Income | 243.89M | 107.03M | 378.24M | 614.64M | 785.10M | 27.7% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $3 | $1 | $4 | $6 | $8 | 27.1% | |
| Weighted Avg Shares Outstanding | 97.53M | 99.71M | 98.79M | 98.58M | 98.20M | -0.4% | |
| Weighted Avg Shares Outstanding (Diluted) | 98.33M | 100.25M | 99.36M | 99.07M | 98.70M | -0.4% | |
EBITDA | 1.01B | 1.23B | 1.41B | 1.36B | 1.59B | 17.4% |
Explore STE
STE in the Healthcare
Large Cap